Physician profile
Molly E Sheeley
NPI 1376045187
$7,167.05
in general payments reported to CMS, 2019-2025
40 companies · $1,324 in 2025
The $1,324 reported for 2025 was more than what 90% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,141 · 2022: $1,015 · 2023: $840 · 2024: $2,848 · 2025: $1,324.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,793 · Consulting Fee: $900 · Travel and Lodging: $318.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,793.38 |
| Consulting Fee | $900.00 |
| Travel and Lodging | $318.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $1,599.59 | 2021-2025 | Erleada |
| Bayer Healthcare Pharmaceuticals INC. | $584.50 | 2021-2025 | |
| Astellas Pharma US INC | $550.83 | 2021-2025 | Xtandi, Myrbetriq |
| Dendreon Pharmaceuticals LLC | $509.41 | 2021-2025 | Provenge |
| Abbvie INC. | $377.73 | 2023-2025 | |
| Boston Scientific Corporation | $306.03 | 2022-2025 | Axonics |
| Axonics, INC. | $275.41 | 2021-2024 | Axonics |
| Coloplast Corp | $249.19 | 2021-2024 | Speedicath |
| Sumitomo Pharma America, INC. | $242.59 | 2023-2025 | Gemtesa, Orgovyx |
| Urogen Pharma, INC. | $196.10 | 2021-2025 | Jelmyto |
| Teleflex LLC | $180.43 | 2021-2025 | Urolift, Barrigel |
| Accord Healthcare, INC. | $174.56 | 2023-2025 | |
| Allergan, INC. | $147.56 | 2021-2022 | |
| Antares Pharma, INC. | $142.23 | 2021-2025 | Xyosted |
| Procept Biorobotics Corporation | $139.81 | 2024-2025 | Aquabeam System |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $134.90 | 2021-2025 | |
| Endo Pharmaceuticals INC. | $128.89 | 2021-2023 | Aveed, Xiaflex |
| Janssen Scientific Affairs, LLC | $124.22 | 2025 | Erleada, Pipeline |
| Medtronic, INC. | $120.00 | 2025 | Interstim |
| Merck Sharp & Dohme LLC | $113.82 | 2021-2024 | Lynparza, Welireg, Keytruda |
| 180 Medical, INC. | $106.80 | 2021-2025 | |
| Immunitybio, INC. | $105.48 | 2024-2025 | |
| Sun Pharmaceutical Industries INC. | $80.68 | 2022-2024 | |
| Tolmar Pharmaceuticals, INC. | $75.51 | 2021-2022 | |
| Blue Earth Diagnostics | $62.48 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $54.79 | 2022-2025 | Lynparza |
| Myovant Sciences INC. | $50.43 | 2022 | |
| Calyxo, INC. | $44.75 | 2025 | Cvac Aspiration System |
| Convatec INC. | $41.37 | 2022 | |
| Ferring Pharmaceuticals INC. | $36.93 | 2024 | Adstiladrin |
| Verity Pharmaceuticals INC. | $34.43 | 2025 | Tlando |
| Clarus Therapeutics INC. | $32.08 | 2021 | |
| Angiodynamics, INC. | $28.91 | 2023-2024 | Nanoknife |
| Halozyme INC | $19.80 | 2023 | |
| Kowa Pharmaceuticals America, INC. | $19.33 | 2022 | |
| Photocure INC | $18.55 | 2024 | Cysview |
| Telix Pharmaceuticals | $18.51 | 2024 | Illuccix |
| Profound Medical Corp. | $14.11 | 2022 | |
| Dentsply Ih INC. | $12.34 | 2021 | |
| Urovant Sciences INC | $11.97 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Molly Sheeley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.